SBMA as a model of polyglutamine diseases: generation of a suitable cell system to study the post-transcriptional modifications of mutant androgen receptor and to discover potential therapeutic drugs

Projektinformationen

PolyQ mutant AR/SBMA

ID Finanzhilfevereinbarung: 300723

Projekt abgeschlossen

Startdatum 1 April 2013

Enddatum 31 März 2015

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 178 760,70

EU-Beitrag € 178 760,70

Koordiniert durch

FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
Italy